EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management

dc.authorid0000-0002-3217-5089
dc.authorid0000-0002-4882-4311
dc.authorid0000-0002-5989-1253
dc.authorid0000-0002-5517-2980
dc.contributor.authorStein, Raimund
dc.contributor.authorBogaert, Guy A.
dc.contributor.authorDogan, Hasan S.
dc.contributor.authorHoen, Lisette
dc.contributor.authorKocvara, Radim
dc.contributor.authorNijman, Rien J. M.
dc.contributor.authorQuadackers, Josine
dc.date.accessioned2025-05-10T19:53:52Z
dc.date.issued2020
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractBackground Treatment in children and adolescents with a neurogenic bladder is primarily conservative with the goal of preserving the upper urinary tract combined with a good reservoir function of the bladder. However, sometimes-even in childhood-conservative management does not prevent the development of a low-compliant bladder or overactive detrusor. Material & Methods After a systematic literature review covering the period 2000-2017, the ESPU/EUAU guideline for neurogenic bladder underwent an update. Results In these patients, surgical interventions such as botulinum toxin A injections into the detrusor muscle, bladder augmentation, and even urinary diversion may become necessary to preserve the function of the upper (and lower) urinary tracts. The creation of a continent catheterizable channel should be offered to patients with difficulties performing transurethral clean intermittent catheterization. However, a revision rate of up to 50% needs to be considered. With increasing age continence of urine and stool becomes progressively more important. In patients with persistent weak bladder outlets, complete continence can be achieved only by surgical interventions creating a higher resistance/obstruction at the level of the bladder outlet with a success rate of up to 80%. In some patients, bladder neck closure and the creation of a continent catheterizable stoma is an option. Conclusion In all these patients close follow-up is mandatory to detect surgical complications and metabolic consequences early.
dc.identifier.doi10.1002/nau.24248
dc.identifier.endpage506
dc.identifier.issn0733-2467
dc.identifier.issn1520-6777
dc.identifier.issue2
dc.identifier.pmid31794087
dc.identifier.scopus2-s2.0-85076231573
dc.identifier.scopusqualityQ2
dc.identifier.startpage498
dc.identifier.urihttps://doi.org/10.1002/nau.24248
dc.identifier.urihttps://hdl.handle.net/20.500.14730/12869
dc.identifier.volume39
dc.identifier.wosWOS:000500093100001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherWiley
dc.relation.ispartofNeurourology and Urodynamics
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WOS_20250302
dc.subjectbladder augmentation
dc.subjectbladder neck reconstruction
dc.subjectEAU guideline
dc.subjectMitrofanoff stoma
dc.subjectneurogenic bladder
dc.subjectsling procedure
dc.subjecturinary diversion
dc.titleEAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management
dc.typeReview

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
12869.pdf
Boyut:
976.19 KB
Biçim:
Adobe Portable Document Format